Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Fast Forward

London theater changes character’s name following antisemitism charges

(JTA) — A theater in London apologized for the “unconscious bias” that led a playwright to give a billionaire character a Jewish-sounding name in a play set to open this week.

The Royal Court Theatre issued the apology Saturday over the name Hershel Fink, which was applied to the character of a high-tech executive in the play “Rare Earth Mettle,” by Al Smith. The character, which closely resembles Tesla founder Elon Musk, is not Jewish and the play makes no references to any Jewish identity, the theater said.

“We acknowledge that this is an example of unconscious bias and we will reflect deeply on how this has happened in the coming days,” the theater, which is part of the English Stage Company, a prominent thespian non-profit, wrote on Instagram Saturday. “We and the writer are deeply sorry for harm caused. In response to our learning the writer has changed the name, as of last night.”

The character will be renamed Henry Finn, according to a statement by the theater Saturday.

The apology followed criticism on social media by professionals in the entertainment industry in the United Kingdom, the Guardian reported, including director Adam Lenson and comedian David Baddiel. Both Baddiel and Lenson are Jewish.

In a tweet, Lenson faulted Smith and the Royal Court Theatre for creating “a character so clearly based on Elon Musk” and then giving him “an obviously Jewish name.” This “perpetuates antisemitic stereotypes and will cause ideological harm,” Lenson wrote.


The post Royal Court Theatre changes character’s name following antisemitism charges appeared first on Jewish Telegraphic Agency.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

—  Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.